RAPT Therapeutics, Inc. (RAPT)
Mar 3, 2026 - RAPT was delisted (reason: acquired by GSK)
58.02
0.00 (0.00%)
Inactive · Last trade price
on Mar 2, 2026
RAPT Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
60
Market Cap
1.79B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRAPT News
- 5 weeks ago - Halper Sadeh LLC Encourages PEN and RAPT Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewsWire
- 6 weeks ago - Forbion Announces Second Exit from Forbion Growth Fund III Following $2.2 Billion Acquisition of RAPT Therapeutics by GSK - GlobeNewsWire
- 6 weeks ago - RAPT Therapeutics shares surge 64% as GSK agrees $2.2B acquisition - Invezz
- 6 weeks ago - GSK to buy food allergy drug maker RAPT in $2.2bn deal - The Guardian
- 6 weeks ago - This Biotech Stock Surges 64%. The Big Pharma M&A Battle Is Heating Up. - Barrons
- 6 weeks ago - GSK to buy RAPT Therapeutics for $2.2 billion - Reuters
- 7 weeks ago - RAPT Therapeutics, Inc. (RAPT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - RAPT Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire